Skip to content

Clinical trials

Completed Lymphoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Status: Completed Country / region: China Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20072
20081
20092
20101
20112
20131
20141
20163
20176
20185
20192
20204
20218
20226
20235

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda4
Fudan University3
Janssen Research & Development, LLC3
BeiGene2
Beijing Friendship Hospital2
Hoffmann-La Roche2
National Cancer Institute (NCI)2
Shanghai Junshi Bioscience Co., Ltd.2
Bayer1
Beijing Boren Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma51
Lymphoma, Large B-Cell, Diffuse6
Leukemia5
Lymphoma, B-Cell4
Lymphoma, Follicular3
Lymphoma, Non-Hodgkin3
Recurrence3
Hematologic Diseases2
Hepatitis B2
Lymphohistiocytosis, Hemophagocytic2

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.